Product image of Glycopyrronium Bromide Morningside Healthcare (Glycopyrronium Bromide) supplied by GNH India

Glycopyrronium Bromide Morningside Healthcare

Active Ingredient:
Glycopyrronium Bromide
Origin:
EU

Glycopyrronium Bromide Morningside Healthcare (Glycopyrronium Bromide)

Glycopyrronium Bromide Morningside Healthcare is a prescription injectable medication containing the anticholinergic agent glycopyrronium bromide. It is supplied as a sterile solution for intramuscular or intravenous administration. The product is marketed in the European Union and is used under medical supervision to manage secretions and support bronchodilation in specific clinical settings. It belongs to the muscarinic antagonist class and works by competitively blocking acetylcholine receptors in the airway and salivary glands.

Manufacturer / TM Owner

Morningside Healthcare Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glycopyrronium bromide is employed in several peri‑operative and respiratory care scenarios.

  • Reduce salivary and respiratory secretions before surgery.
  • Provide bronchodilation for patients with chronic obstructive pulmonary disease (COPD).
  • Adjunct to anesthesia to decrease airway reflexes.
  • Facilitate intubation by minimizing secretions.
  • Used in intensive care settings to manage excessive airway secretions.

Side Effects

Side effects of glycopyrronium bromide vary in frequency and severity.

Common

  • Dry mouth.
  • Reduced sweating.
  • Blurred vision.
  • Constipation.
  • Urinary retention.

Serious

  • Tachycardia.
  • Severe allergic reaction (anaphylaxis).
  • Acute angle‑closure glaucoma.
  • Cardiac arrhythmias.

Precautions & Warnings

Clinicians should consider several precautions when prescribing glycopyrronium bromide.

  • Assess cardiovascular status before use.
  • Use cautiously in patients with glaucoma.
  • Monitor for urinary retention in those with prostate enlargement.
  • Avoid in patients with known hypersensitivity to anticholinergics.
  • Adjust dose in renal impairment.
  • Consider fetal risk; safety in pregnancy not established.

Avoid Interactions

Glycopyrronium bromide may interact with other medications, requiring attention to avoid adverse effects.

Avoid

  • Concurrent use with other anticholinergic agents (e.g., atropine, scopolamine).
  • Combination with beta‑agonists that may increase heart rate excessively.

Use with caution

  • Concurrent beta‑blockers (may mask tachycardia).
  • Drugs that prolong QT interval (e.g., certain antiarrhythmics).
  • Anesthetic agents that depress respiration.
  • Medications affecting renal clearance.

Frequently Asked Questions

It is used to reduce salivary and respiratory secretions, helping keep the airway clear during anesthesia.

The drug acts as a bronchodilator by blocking muscarinic receptors, which relaxes airway smooth muscle and improves airflow.

Yes, it is formulated for both intramuscular and intravenous injection under medical supervision.

Common adverse effects include dry mouth, reduced sweating, blurred vision, constipation, and urinary retention.

Serious reactions may include tachycardia, severe allergic response (anaphylaxis), acute angle‑closure glaucoma, and cardiac arrhythmias.

Patients with glaucoma should use the medication with caution because anticholinergic effects can increase intra‑ocular pressure.

Safety in pregnancy has not been established; the drug should be used only if the potential benefit justifies the potential risk.

Concurrent use with other anticholinergic agents and beta‑agonists that may excessively raise heart rate should be avoided.

Yes, beta‑blockers may mask tachycardia, so the combination should be used with caution and patients monitored closely.

Monitoring of cardiovascular status, urinary output, and signs of excessive anticholinergic effect (e.g., dry mouth, blurred vision) is recommended.

Dose adjustment may be required in renal impairment; clinicians should assess renal function before initiating therapy.

It competitively antagonizes muscarinic acetylcholine receptors, reducing secretions and causing bronchodilation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glycopyrronium Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT